Latest filing published 10 Apr 2022 for ImmunoPrecise Antibodies Ltd..
No signal scores available.
Carla Cherry Dahl appears in our data through filings on ImmunoPrecise Antibodies Ltd. shares, published by SEDI. In total, 2 filings cover trades dated from 2 August 2021 to 6 April 2022.
Every open-market trade on record is a purchase: 1 purchase worth €44k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2022: 1 purchase and no sales on the market.
The newest entry dates from 10 April 2022: a transaction, in ImmunoPrecise Antibodies Ltd. The latest purchase dates back some time: it was published 1,660 days ago, on 10 April 2022. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations